Dual path immunoassay device

• US 20060205059A1
• Filed: 06/30/2005
• Published: 09/14/2006
• Est. Priority Date: 03/11/2005
• Status: Active Grant

• Current Assignee: Chembio Diagnostic Systems Incorporated (Chembio Diagnostics, Inc.)
• Original Assignee: Chembio Diagnostic Systems Incorporated (Chembio Diagnostics, Inc.)
• Inventors: Esfandiari, Javanbakhsh
• Granted Patent: US 7,189,522 B2
• Time in Patent Office: Days
• US Class Current: 435/287.200
• CPC Class Codes: G01N 33/538 by sorbent column, particles or resin strip , i.e. sorbent materials
• CPC Class Codes: G01N 33/5695 Mycobacteria
• CPC Class Codes: G01N 33/56988 HIV or HTLV

Abstract

The systems of the invention include test cells with a first sorbent material defining a first flow path for a solution, a second sorbent material defining a second flow path distinct from the first flow path for a sample, and a test line or test site with immobilized antigens or antibodies or other ligand binding molecules such as aptamers, nucleic acids, etc. located at the junction of the first and second sorbent materials. The first and second sorbent strips touch each other at the test site location.

Claims

1. A test device for determining the presence of a ligand in a liquid sample, comprising:

a) a first sorbent strip having a first location for receiving a solution and defining a first migration path;

b) a second sorbent strip distinct from said first sorbent strip having a second location for receiving the liquid sample and defining a second migration path distinct from said first migration path; and

c) a test site located on or in at least one of said first sorbent strip or said second sorbent strip, said test site having an immobilized ligand-binding mechanism, and said first and second sorbent strips touching each other at the test site.

2. A test device according to claim 1, further comprising:

d) a housing defining a first opening adjacent said first location, a second opening adjacent said second location, and a window adjacent said test site through which said test site is viewable.

3. A test device according to claim 1, wherein:

said first sorbent strip supports a conjugate.

4. A test device according to claim 3, wherein:

said ligand-binding mechanism is an antigen or antibody for said ligand, and said conjugate comprises an antigen or antibody for the ligand and a marker coupled to the antigen or antibody.

5. A test device according to claim 4, wherein:

said marker is a colored marker viewable in the visible spectrum.

6. A test device according to claim 2, wherein:

one or both of said first and second sorbent strips includes a control site, and said housing defines a window for viewing said control site.

7. A test device according to claim 1, wherein:

said first sorbent strip and said second sorbent strip are arranged in a “

T”

configuration.

8. A test device according to claim 1, wherein:

said first sorbent strip and second sorbent strip are arranged in a “

+”

configuration.

9. A test device according to claim 1, wherein:

said first sorbent strip has a first pore size and said second sorbent strip has a second pore size.

10. A test device according to claim 9, wherein:

said second pore size is larger than said first pore size.

11. A test device according to claim 10, wherein:

said first pore size is between 3 and 20 microns, and

said second pore size is between 20 and 40 microns.

12. A test device according to claim 2, wherein:

one or both of said first and second sorbent strips includes a control site, and either said window is sized to permit viewing of said control site or a second window is provided in said housing to permit viewing of said control site.

13. A test device according to claim 1, further comprising:

said solution wherein said solution comprises a buffer.

14. A test device according to claim 1, further comprising:

said solution wherein said solution comprises a subsystem of a buffer and a conjugate having an antigen or antibody for the ligand and a marker coupled to the antigen or antibody.

15. A test device according to claim 1, wherein:

said immobilized ligand-binding mechanism comprises an HIV antigen or antibody.

16. A test device according to claim 1, wherein:

said immobilized ligand-binding mechanism has one of comprises antigens, antibodies, aptamers, nucleic acids, or enzymes for testing for at least one of pregnancy, HIV, tuberculosis (TB), prion, urine-analysis/drug, Chlamydia, cardiac markers, cancer markers, Chagas, dental bacteria (SM/LC), strep A, influenza A, influenza B, adenovirus/rotavirus, CPV, FIV, FeLV, and heartworm.

17. A test device according to claim 1, wherein:

said first sorbent strip includes a first membrane and a first backing and said second sorbent strip includes a second membrane and a second backing, and said first sorbent strip and said second sorbent strip are arranged such that said first membrane is in contact with said second membrane.

18. A test device according to claim 17, further comprising:

a first adhesive backing card underlying or overlying said first sorbent strip.

19. A test device according to claim 18, further comprising:

a second adhesive backing card underlying or overlying said second sorbent strip.

20. A test device according to claim 1, wherein:

said first sorbent strip and said second sorbent strip include a single membrane integral to both of said first sorbent strip and said second sorbent strip.

21. A test device according to claim 1, wherein:

said test device is for determining the presence of a plurality of different ligands in the liquid sample, and

said test site has a plurality of separate immobilized ligand-binding mechanisms for separately binding to respective of said plurality of different ligands.

22. A test device according to claim 21, wherein:

said plurality of separate immobilized ligand-binding mechanisms includes a tuberculosis antigen and at least one HIV antigen.

23. A test device according to claim 21, wherein:

said plurality of separate immobilized ligand-binding mechanisms includes p24 antibodies and at least one of an HIV1 and an HIV2 antigen.

24. A test device according to claim 21, wherein:

said first sorbent strip supports a plurality of different conjugates comprising antigens and/or antibodies for the plurality of different ligands and markers coupled to the antigens and/or antibodies.

25-32. -32. (canceled)

33. A test device for determining the presence of a ligand in a liquid sample, comprising:

a) a first sorbent strip having a first location for receiving a solution and defining a first migration path;

b) a second sorbent strip distinct from said first sorbent strip having a second location for receiving the liquid sample and defining a second migration path distinct from said first migration path; and

c) a test site located on or in at least one of said first or second sorbent strips, said test site having an immobilized ligand-binding mechanism deposited on or in the at least one of said first or second sorbent strips, said first and second sorbent strips in direct contact with each other at the test site.

34. (canceled)

35. (canceled)